Insider Buying: Hyperion DeFi (NASDAQ:HYPD) Director Buys 12,112 Shares of Stock

Hyperion DeFi, Inc. (NASDAQ:HYPD) Director Ellen Strahlman bought 12,112 shares of the stock in a transaction on Monday, December 29th. The stock was purchased at an average price of $3.60 per share, for a total transaction of $43,603.20. Following the completion of the purchase, the director owned 91,161 shares of the company’s stock, valued at approximately $328,179.60. This trade represents a 15.32% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Hyperion DeFi Stock Performance

Shares of HYPD stock traded down $0.13 on Tuesday, hitting $3.37. 193,370 shares of the stock were exchanged, compared to its average volume of 1,525,525. The firm’s 50 day moving average is $4.87 and its two-hundred day moving average is $7.60. Hyperion DeFi, Inc. has a one year low of $0.85 and a one year high of $17.99. The firm has a market capitalization of $27.53 million, a PE ratio of -0.83 and a beta of 2.81. The company has a current ratio of 2.25, a quick ratio of 2.25 and a debt-to-equity ratio of 0.11.

Hyperion DeFi (NASDAQ:HYPD) last issued its earnings results on Friday, November 14th. The company reported $0.05 earnings per share (EPS) for the quarter. Hyperion DeFi had a negative net margin of 62,238.41% and a negative return on equity of 119.59%. The business had revenue of $0.36 million for the quarter. Sell-side analysts expect that Hyperion DeFi, Inc. will post -41.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

HYPD has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperion DeFi in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Hyperion DeFi from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. Cantor Fitzgerald began coverage on shares of Hyperion DeFi in a report on Tuesday, December 16th. They set an “overweight” rating and a $4.00 target price on the stock. Finally, Chardan Capital set a $7.75 target price on shares of Hyperion DeFi and gave the stock a “buy” rating in a research note on Wednesday, December 24th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $4.58.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.